ArticleFrontiers in immunology2023

Efficient and stable CRISPR/Cas9-mediated genome-editing of human type 2 innate lymphoid cells.

Johanne Audouze-Chaud et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.